SCHEMBL4933366

SCHEMBL4933366

O=C(O)CCc1cc(Cl)c(OCc2cc(Cl)cc(NC3CCC3)c2)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRA P10827 11/20 0.45
THRB P10828 11/20 0.45
ENPP2 Q13822 2/20 0.39
ESR1 P03372 1/20 0.38
NR3C1 P04150 1/20 0.38
PGR P06401 1/20 0.38
NR3C2 P08235 1/20 0.38
AR P10275 1/20 0.38
FFAR1 O14842 2/20 0.36
FFAR4 Q5NUL3 1/20 0.36
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
OPRK1 P41145 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4351503 0.90 THRA (0.57) THRATHRBENPP2ESR1NR3C1
SCHEMBL4933102 0.89 ACLY (0.43) THRATHRBESR1NR3C1PGR
SCHEMBL4531944 0.89 THRA (0.45) THRATHRBESR1NR3C1PGR
SCHEMBL4933093 0.87 FFAR4 (0.41) THRATHRBENPP2ESR1NR3C1
SCHEMBL4930094 0.87 THRA (0.48) THRATHRBFFAR1FFAR4
SCHEMBL4931458 0.84 THRA (0.40) THRATHRBENPP2MEN1ALDH1A1
SCHEMBL4357988 0.83 THRA (0.55) THRATHRBESR1NR3C1PGR
SCHEMBL4932312 0.83 THRA (0.45) THRATHRBENPP2ESR1NR3C1
SCHEMBL4929570 0.82 FFAR1 (0.35) ENPP2FFAR1KDM4EMEN1ALDH1A1
SCHEMBL4926882 0.82 PDE4A (0.36) ENPP2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA THRA 3/4885THRB 4/4885ENPP2 814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.